HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide (Q38459524)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 2001
edit
Language Label Description Also known as
English
HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide
scientific article published on August 2001

    Statements

    HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide (English)
    A Di Leo
    D Larsimont
    D Gancberg
    T Jarvinen
    M Beauduin
    A Vindevoghel
    J Michel
    C H Focan
    P H Gobert
    M T Closon-Dejardin
    S Dolci
    G Rouas
    M Paesmans
    J P Lobelle
    J Isola
    M J Piccart
    1 August 2001
    1081-1089

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit